Cargando…

Pre-diabetes in the elderly and the see-saw model of paternalism

Pre-diabetes is a risk factor for the development of diabetes, not a disease in its own right. The prevalence increases with age and reaches nearly 50% of those aged over 75 years in the USA. While lifestyle modification and treatment are likely to benefit those with many years of life ahead of them...

Descripción completa

Detalles Bibliográficos
Autores principales: Burch, Patrick, Holm, Soren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562306/
https://www.ncbi.nlm.nih.gov/pubmed/33148775
http://dx.doi.org/10.1136/medethics-2020-106573
_version_ 1784593236631748608
author Burch, Patrick
Holm, Soren
author_facet Burch, Patrick
Holm, Soren
author_sort Burch, Patrick
collection PubMed
description Pre-diabetes is a risk factor for the development of diabetes, not a disease in its own right. The prevalence increases with age and reaches nearly 50% of those aged over 75 years in the USA. While lifestyle modification and treatment are likely to benefit those with many years of life ahead of them, they are unlikely to benefit patients with a limited life expectancy. Despite this, some very elderly patients in the UK and elsewhere are being labelled as pre-diabetic. While ideal practice would be to carefully consider the impact of any potentially abnormal blood test before it is taken, this is not always possible in routine practice. In this paper, we discuss a pragmatic, ethical approach for clinicians managing pre-diabetic blood tests in very elderly patients. We argue that a ‘see-saw’ model of paternalism should be used in deciding which patients to inform that they can be labelled as pre-diabetic. Those patients that may benefit from the label should be informed, and those that will not, should not. Where the benefits/drawbacks are unclear, the result and its potential significance should be discussed in depth with the individual patient. We do not advocate withholding information from any patient. Instead we suggest clinicians use individual patient circumstances to contextualise the relevance of pre-diabetes to the patient and consider the benefits and drawbacks before informing them. This approach has the potential to be used for other pre-conditions and risk factors in addition to pre-diabetes.
format Online
Article
Text
id pubmed-8562306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85623062021-11-15 Pre-diabetes in the elderly and the see-saw model of paternalism Burch, Patrick Holm, Soren J Med Ethics Clinical Ethics Pre-diabetes is a risk factor for the development of diabetes, not a disease in its own right. The prevalence increases with age and reaches nearly 50% of those aged over 75 years in the USA. While lifestyle modification and treatment are likely to benefit those with many years of life ahead of them, they are unlikely to benefit patients with a limited life expectancy. Despite this, some very elderly patients in the UK and elsewhere are being labelled as pre-diabetic. While ideal practice would be to carefully consider the impact of any potentially abnormal blood test before it is taken, this is not always possible in routine practice. In this paper, we discuss a pragmatic, ethical approach for clinicians managing pre-diabetic blood tests in very elderly patients. We argue that a ‘see-saw’ model of paternalism should be used in deciding which patients to inform that they can be labelled as pre-diabetic. Those patients that may benefit from the label should be informed, and those that will not, should not. Where the benefits/drawbacks are unclear, the result and its potential significance should be discussed in depth with the individual patient. We do not advocate withholding information from any patient. Instead we suggest clinicians use individual patient circumstances to contextualise the relevance of pre-diabetes to the patient and consider the benefits and drawbacks before informing them. This approach has the potential to be used for other pre-conditions and risk factors in addition to pre-diabetes. BMJ Publishing Group 2021-11 2020-11-04 /pmc/articles/PMC8562306/ /pubmed/33148775 http://dx.doi.org/10.1136/medethics-2020-106573 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Clinical Ethics
Burch, Patrick
Holm, Soren
Pre-diabetes in the elderly and the see-saw model of paternalism
title Pre-diabetes in the elderly and the see-saw model of paternalism
title_full Pre-diabetes in the elderly and the see-saw model of paternalism
title_fullStr Pre-diabetes in the elderly and the see-saw model of paternalism
title_full_unstemmed Pre-diabetes in the elderly and the see-saw model of paternalism
title_short Pre-diabetes in the elderly and the see-saw model of paternalism
title_sort pre-diabetes in the elderly and the see-saw model of paternalism
topic Clinical Ethics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562306/
https://www.ncbi.nlm.nih.gov/pubmed/33148775
http://dx.doi.org/10.1136/medethics-2020-106573
work_keys_str_mv AT burchpatrick prediabetesintheelderlyandtheseesawmodelofpaternalism
AT holmsoren prediabetesintheelderlyandtheseesawmodelofpaternalism